DIABETIC MACROANGIOPATHY

DIABETIC MACROANGIOPATHY was reported 33 times

These drug classes are most commonly taken by patients reporting DIABETIC MACROANGIOPATHY:

# Drug Count
0 Interleukin-2 Receptor Blocking Antibody [EPC] 15
1 Benzodiazepine [EPC] 14
2 Oxazolidinone Antibacterial [EPC] 13
3 P2Y12 Platelet Inhibitor [EPC] 12
4 Azole Antifungal [EPC] 11
5 Corticosteroid [EPC] 11
6 Fluoroquinolone Antibacterial [EPC] 11
7 Penem Antibacterial [EPC] 11
8 Insulin Analog [EPC] 10
9 Antimetabolite Immunosuppressant [EPC] 8
10 Catecholamine [EPC] 7
11 Angiotensin 2 Receptor Blocker [EPC] 5
12 Angiotensin Converting Enzyme Inhibitor [EPC] 3
13 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 3
14 HMG-CoA Reductase Inhibitor [EPC] 3
15 Nonsteroidal Anti-inflammatory Drug [EPC] 3
16 Platelet Aggregation Inhibitor [EPC] 3
17 Sulfonamide Antimicrobial [EPC] 3
18 Calcineurin Inhibitor Immunosuppressant [EPC] 2
19 GLP-1 Receptor Agonist [EPC] 2
20 Loop Diuretic [EPC] 2
21 Proton Pump Inhibitor [EPC] 2
22 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 2
23 alpha-Adrenergic Blocker [EPC] 2
24 beta-Adrenergic Blocker [EPC] 2
25 Aminoglycoside Antibacterial [EPC] 1
26 Calcium Channel Blocker [EPC] 1
27 Cytochrome P450 3A Inhibitor [EPC] 1
28 Dietary Cholesterol Absorption Inhibitor [EPC] 1
29 Dihydropyridine Calcium Channel Blocker [EPC] 1
30 Dipeptidyl Peptidase 4 Inhibitor [EPC] 1
31 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1
32 Interferon beta [EPC] 1
33 Opioid Agonist [EPC] 1
34 Protease Inhibitor [EPC] 1
35 Sulfonylurea [EPC] 1